Microsoft and Adaptive Biotechnologies to map COVID-19 immune responses using Azure and immune-receptor sequencing starting in April
Microsoft and Adaptive Biotechnologies will collaborate to map population-wide immune responses to COVID-19 by sequencing de-identified blood samples starting in April, analyzing results with Microsoft’s machine-learning tools on Azure, and publishing findings in an open data portal to aid diagnostics and therapies.